feed,title,long_url,short_url
BioRxiv,P2G3 human monoclonal antibody neutralizes SARS-CoV-2 Omicron subvariants including BA.4 and BA.5 and Bebtelovimab escape mutants,https://biorxiv.org/cgi/content/short/2022.07.28.501852v1?rss=1,https://bit.ly/3S6wYOu
BioRxiv,Molecular basis for antiviral activity of pediatric neutralizing antibodies targeting SARS-CoV-2 Spike receptor binding domain,https://biorxiv.org/cgi/content/short/2022.07.27.501708v1?rss=1,https://bit.ly/3vnPNTB
BioRxiv,Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 Variants,https://biorxiv.org/cgi/content/short/2022.07.27.501719v1?rss=1,https://bit.ly/3vqMHOF
